Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Studies suggest psychotropic polypharmacy may be on the rise. But experts say whether that’s good or bad — or even ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Jared Stanley, Chief Executive Officer, and Joel Stanley, ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

A holistic approach emphasizes lifestyle choices, nutrition, exercise, stress management, medications where appropriate, and ...

Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Obstructive sleep apnoea, strongly linked to obesity, can lead to severe health complications, highlighting the need for ...

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

The global next-generation titrator market is on an impressive growth trajectory, with market size expected to surge from USD 3,820.6 million in 2024 to USD 7,171.9 million by 2034. This expansion, at ...